Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
2646 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-12-17 (marketbeat.com)
Franklin Resources Inc. Sells 13,723 Shares of Biogen Inc. (NASDAQ:BIIB)
Franklin Resources Inc. cut its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 374,747 shares of the biotechnology company's stock after selling 13,723 shares during the period. Frankli
Read more
2024-12-16 (bolsamania.com)
BIOGEN IDEC Quote: Shares and information - .com
Receive in your email: breaking news, technical analysis or market closing
Read more
2024-11-22 (marketbeat.com)
Biogen Inc. (NASDAQ:BIIB) Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A.
BNP PARIBAS ASSET MANAGEMENT Holding S.A. decreased its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 7.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 399,404 shares of the biotechnolog
Read more
2024-11-13 (marketbeat.com)
Biogen Inc. (NASDAQ:BIIB) Shares Sold by ICICI Prudential Asset Management Co Ltd
ICICI Prudential Asset Management Co Ltd trimmed its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 23.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,368 shares of the
Read more
2024-11-10 (aktiencheck.de)
Biogen shares: unrest in the management team ()
Biogen shares: unrest in the management suite () | aktiencheck.de
Read more
2024-09-30 (marketbeat.com)
Saratoga Research & Investment Management Sells 5,060 Shares of Biogen Inc. (NASDAQ:BIIB)
Saratoga Research & Investment Management lessened its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 157,791 shares of the biotechnology c
Read more
2024-09-11 (finmarket.ru)
Finam raised its target price for Biogen shares to $241.7
Finam raised its target price for Biogen Inc. shares. to $241.7 per share, which implies a growth potential of 20.4% over a 12-month horizon, according to a commentary by the leading analyst of the investment company Zarina Saidova.
Read more
2024-06-26 (aktiencheck.de)
Biogen shares: Investors beware! ()
Biogen shares: Investors beware! () | aktiencheck.de
Read more
2024-06-10 (tijd.be)
5 favorite shares of Joost Olbrechts: 'This share is betting on the Next AI wave'
The investment advisor chooses shares in Brussels, Zurich, Wall Street and Singapore.
Read more